A cross-sectional study found that while the Inflation Reduction Act capped out-of-pocket drug costs for Medicare Part D beneficiaries at $2,000 starting in 2025, many enrollees may still face higher ...

Medicare enrollees who buy the optional Part D drug benefit may see substantial premium price hikes — potentially up to $50 a month — when they shop for next year’s coverage.

MOSCOW (Reuters) -Russia's central bank may be able to cut its key interest rate from 18% this year if inflation slows rapidly, but it does not rule out holding it at that level in order to achieve a ...

A JAMA study published Aug. 18 found that plan design changes by Medicare Part D insurers, particularly for Medicare Advantage plans, following passage of the Inflation Reduction Act of 2022 could ...

Environmental Protection Agency Director Lee Zeldin told Miranda Devine, during an interview on her "Pod Force One" podcast, that $20 billion was laundered through a network of "pass-through" NGOs ...

The Environmental Protection Agency (EPA) has canceled more than $29 billion in federal grants, a move the agency’s administrator, Lee Zeldin, says is ...

Russia's economy is cooling, with some officials warning of recession risks, and though interest rates are starting to come ...

Since 2023, the Inflation Reduction Act (IRA) has capped the cost of insulin for Medicare beneficiaries at $35 per month.

The Environmental Protection Agency (EPA) has canceled more than $29 billion in federal grants, said Administrator Lee Zeldin ...

A new study finds Medicare beneficiaries are facing higher deductibles and cost-sharing requirements following changes ...

Democrats’ Inflation Reduction Act passed the House of Representatives in a 220-207 vote on Friday after clearing the Senate last weekend, and with it, some big changes could be coming to key ...

Cheaper energy bills are a nonpartisan issue—no matter where you live. The second Trump administration is proving to be more ...